Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.77 |
| ▸ | VDR | P11473 | 5/20 | 0.77 |
| ▸ | MEN1 | O00255 | 3/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.77 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.77 |
| ▸ | PGR | P06401 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.77 |
| ▸ | CDC25A | P30304 | 1/20 | 0.77 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.77 |
| ▸ | HPGD | P15428 | 1/20 | 0.77 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.77 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.77 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.77 |
| ▸ | DRD3 | P35462 | 1/20 | 0.77 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22577759 | 1.00 | MAPT (0.77) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL7211135 | 1.00 | MAPT (0.77) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL28255174 | 1.00 | MAPT (0.77) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL15633688 | 0.93 | VDR (0.77) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL10894072 | 0.90 | MAPT (0.78) | MAPTVDRMEN1KMT2AADORA3 | |
| Calcitriol SCHEMBL225412 | 0.89 | VDR (0.83) | MAPTVDRMEN1KMT2AADORA3 | |
| SCHEMBL1890289 | 0.87 | MEN1 (0.71) | MAPTVDRMEN1KMT2AADORA3 | |
| Cholecalciferol SCHEMBL23878716 | 0.87 | MEN1 (1.00) | MAPTVDRMEN1KMT2AADORA3 | |
| Cholecalciferol SCHEMBL20511118 | 0.87 | MEN1 (1.00) | MAPTVDRMEN1KMT2AADORA3 | |
| Cholecalciferol SCHEMBL13717177 | 0.87 | MEN1 (1.00) | MAPTVDRMEN1KMT2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025058988-A1 | METHOD OF TREATING NON-IMMUNOGENIC SKIN CANCERS | THE GENERAL HOSPITAL CORPORATION (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2018071687-A1 | METHODS OF TREATING PRURITIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-04-19 | — | — | WO | claimed |
| US-8338373-B2 | Method for reducing the risk of spontaneous abortion in a human female subject | NORA THERAPEUTICS, INC. (US) | 2012-12-25 | — | — | US | claimed |
| WO-2010126528-A9 | COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION | NORA THERAPEUTICS, INC. (US) | 2010-12-23 | — | — | WO | claimed |
| US-7851461-B2 | acetylsalicylic acid, 1,25 dihydroxycholecalcipherol and calcium | COLOTECH A/S (DK) | 2010-12-14 | — | — | US | claimed |
| WO-2010126528-A1 | COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION | NORA THERAPEUTICS, INC. (US) | 2010-11-04 | — | — | WO | claimed |
| WO-2010126553-A1 | COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR SPONTANEOUS ABORTION IN RECIPIENTS OF ASSISTED REPRODUCTION | NORA THERAPEUTICS, INC. (US) | 2010-11-04 | — | — | WO | claimed |
| US-20100080837-A1 | COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR SPONTANEOUS ABORTION IN RECIPIENTS OF ASSISTED REPRODUCTION | NOVA THERAPEUTICS, INC. (US) | 2010-04-01 | — | — | US | claimed |
| US-20090226397-A1 | COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION | NORA THERAPEUTICS, INC. (US) | 2009-09-10 | — | — | US | claimed |
| EP-1207850-B1 | STRIP PACK | DRUGTECH CORP (US) | 2008-10-22 | — | — | EP | claimed |
| EP-0437225-B1 | Topical preparations | HOFFMANN LA ROCHE (CH) | 1994-04-20 | — | — | EP | claimed |
| EP-0477270-A1 | PREVENTION AND TREATMENT OF MICROBIAL INFECTION BY PHOSPHOGLYCERIDES | MED-TAL, INC. (US) | 1992-04-01 | — | — | EP | claimed |
| US-5039671-A | Bone disorders; calcium or phosphorus inbalance | HOFFMANN-LA ROCHE INC. (US) | 1991-08-13 | — | — | US | claimed |
| WO-1990015609-A1 | PREVENTION AND TREATMENT OF MICROBIAL INFECTION BY PHOSPHOGLYCERIDES | MED-TAL, INC. (US) | 1990-12-27 | — | — | WO | claimed |
| EP-0186102-B1 | CHOLECALCIFEROL DERIVATIVES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1989-05-10 | — | — | EP | claimed |
| EP-0313703-A1 | Use of 24,25-dihydroxycholecalciferole in the treatment of urinary calculus | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-05-03 | — | — | EP | claimed |
| EP-0301167-A1 | A combination of cholecalciferol derivatives for the treatment of renal bone disease | Teva Pharmaceutical Industries Limited (IL) | 1989-02-01 | — | — | EP | claimed |
| EP-0230600-A1 | Production of cholecalciferol derivatives and novel intermediates used therefor | Teva Pharmaceutical Industries Limited (IL) | 1987-08-05 | — | — | EP | claimed |
| US-4617297-A | CALCIUM METABOLIC DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1986-10-14 | — | — | US | claimed |
| US-4612308-A | ANTITUMOR AND ANTILEUKEMIA AGENTS, OSTEOPOROSIS | HOFFMANN-LA ROCHE INC. (US) | 1986-09-16 | — | — | US | claimed |